Romidepsin Alternatives Compared
| Romidepsin | Pralatrexate | Istodax (romidepsin) |
|
|---|
| Romidepsin | Pralatrexate | Istodax (romidepsin) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Cutaneous T-cell Lymphoma, Peripheral T-cell Lymphoma. Romidepsin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Peripheral T-cell Lymphoma, Lymphoma, Non-Hodgkin's Lymphoma. Pralatrexate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cutaneous T-cell Lymphoma, Peripheral T-cell Lymphoma. Istodax may also be used for purposes not listed in this medication guide. |
Related suggestions Peripheral T-cell Lymphoma
|
|||||||||||||||||||||||
| More about Romidepsin | More about Pralatrexate | More about Istodax (romidepsin) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Romidepsin has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Pralatrexate has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Istodax has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Romidepsin side effects |
View all Pralatrexate side effects |
View all Istodax side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Romidepsin prices |
View all Pralatrexate prices |
View all Istodax prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Istodax | Folotyn |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
3 hours |
18 hours |
3 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 514 drugs are known to interact with Romidepsin:
|
A total of 241 drugs are known to interact with Pralatrexate:
|
A total of 514 drugs are known to interact with Istodax:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 13, 2020 |
September 24, 2009 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Zolinza
Zolinza is used to treat skin problems caused by cutaneous T-cell lymphoma. Learn about side ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Beleodaq
Beleodaq (belinostat) interferes with the growth and spread of cancer cells in the body and is used ...
Actimmune
Actimmune is used for chronic granulomatous disease, cutaneous t-cell lymphoma, idiopathic ...
Istodax
Istodax is used to treat T-cell lymphoma affecting the skin. Learn about side effects, interactions ...
Lymphir
Lymphir (denileukin diftitox-cxdl) is an injectable targeted cancer treatment that may be used to ...
Folotyn
Folotyn is used to treat T-cell lymphoma that has spread throughout the body. Learn about side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.